These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26996383)

  • 1. The association between non-alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: A hospital based case-control study.
    Kinoshita M; Kubo S; Tanaka S; Takemura S; Nishioka T; Hamano G; Ito T; Tanaka S; Ohsawa M; Shibata T
    J Surg Oncol; 2016 Jun; 113(7):779-83. PubMed ID: 26996383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
    Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
    Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.
    Hai S; Kubo S; Yamamoto S; Uenishi T; Tanaka H; Shuto T; Takemura S; Yamazaki O; Hirohashi K
    Dig Surg; 2005; 22(6):432-9. PubMed ID: 16479112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.
    Hobeika C; Cauchy F; Poté N; Rautou PE; Durand F; Farges O; Dokmak S; Vilgrain V; Ronot M; Paradis V; Soubrane O
    World J Surg; 2019 Aug; 43(8):2048-2060. PubMed ID: 30949764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma?
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Capelli P; Pedica F; Nicoli P; Conci S; Iacono C
    J Surg Oncol; 2010 Feb; 101(2):111-5. PubMed ID: 19953578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
    Jiang BG; Sun LL; Yu WL; Tang ZH; Zong M; Zhang YJ
    Cancer J; 2009; 15(3):257-61. PubMed ID: 19556914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H; Sato K; Takagi H; Hirokawa T; Kojima A; Sohara N; Kakizaki S; Mochida Y; Shimura T; Sunose Y; Ohwada S; Mori M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocarcinoma: a clinicopathologic study of 37 resected cases.
    Zhu HF; Li J; Huang L; Yan YQ
    Hepatogastroenterology; 2013; 60(122):263-7. PubMed ID: 23574653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
    Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
    J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K; Yamamoto M; Ariizumi S
    Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent intrahepatic cholangiocarcinoma.
    Sulpice L; Rayar M; Boucher E; Pracht M; Meunier B; Boudjema K
    Br J Surg; 2012 Dec; 99(12):1711-7. PubMed ID: 23132419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
    Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
    JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series.
    Wu ZF; Zhang HB; Yang N; Zhao WC; Fu Y; Yang GS
    Eur J Surg Oncol; 2012 Jul; 38(7):602-10. PubMed ID: 22417704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
    Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
    Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.